vs
Side-by-side financial comparison of Dexcom (DXCM) and Huntington Ingalls Industries (HII). Click either name above to swap in a different company.
Huntington Ingalls Industries is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Dexcom). Dexcom runs the higher net margin — 21.2% vs 8.9%, a 12.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 13.8%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -25.2%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Huntington Ingalls Industries, Inc. (HII) is the largest military shipbuilding company in the United States as well as a provider of professional services to partners in government and industry. HII was formed on 31 March 2011, as a divestiture from Northrop Grumman.
DXCM vs HII — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.7B |
| Net Profit | $267.3M | $149.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 9.3% |
| Net Margin | 21.2% | 8.9% |
| Revenue YoY | 21.6% | 13.8% |
| Net Profit YoY | 153.6% | — |
| EPS (diluted) | $0.67 | $3.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.7B | ||
| Q4 25 | $1.3B | $3.5B | ||
| Q3 25 | $1.2B | $3.2B | ||
| Q2 25 | $1.2B | $3.1B | ||
| Q1 25 | $1.0B | $2.7B | ||
| Q4 24 | $1.1B | $3.0B | ||
| Q3 24 | $994.2M | $2.7B | ||
| Q2 24 | $1.0B | $3.0B |
| Q1 26 | $267.3M | $149.0M | ||
| Q4 25 | $267.3M | $159.0M | ||
| Q3 25 | $283.8M | $145.0M | ||
| Q2 25 | $179.8M | $152.0M | ||
| Q1 25 | $105.4M | $149.0M | ||
| Q4 24 | $151.7M | $123.0M | ||
| Q3 24 | $134.6M | $101.0M | ||
| Q2 24 | $143.5M | $173.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 9.3% | ||
| Q4 25 | 25.6% | 4.9% | ||
| Q3 25 | 20.1% | 5.0% | ||
| Q2 25 | 18.4% | 5.3% | ||
| Q1 25 | 12.9% | 5.9% | ||
| Q4 24 | 17.0% | 3.7% | ||
| Q3 24 | 15.3% | 3.0% | ||
| Q2 24 | 15.7% | 6.3% |
| Q1 26 | 21.2% | 8.9% | ||
| Q4 25 | 21.2% | 4.6% | ||
| Q3 25 | 23.5% | 4.5% | ||
| Q2 25 | 15.5% | 4.9% | ||
| Q1 25 | 10.2% | 5.4% | ||
| Q4 24 | 13.6% | 4.1% | ||
| Q3 24 | 13.5% | 3.7% | ||
| Q2 24 | 14.3% | 5.8% |
| Q1 26 | $0.67 | $3.79 | ||
| Q4 25 | $0.67 | $4.06 | ||
| Q3 25 | $0.70 | $3.68 | ||
| Q2 25 | $0.45 | $3.86 | ||
| Q1 25 | $0.27 | $3.79 | ||
| Q4 24 | $0.37 | $3.15 | ||
| Q3 24 | $0.34 | $2.56 | ||
| Q2 24 | $0.35 | $4.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $216.0M |
| Total DebtLower is stronger | — | $2.7B |
| Stockholders' EquityBook value | $2.7B | $5.1B |
| Total Assets | $6.3B | $12.5B |
| Debt / EquityLower = less leverage | — | 0.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $216.0M | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | $5.1B | ||
| Q4 25 | $2.7B | $5.1B | ||
| Q3 25 | $2.7B | $5.0B | ||
| Q2 25 | $2.6B | $4.9B | ||
| Q1 25 | $2.3B | $4.8B | ||
| Q4 24 | $2.1B | $4.7B | ||
| Q3 24 | $2.0B | $4.2B | ||
| Q2 24 | $2.4B | $4.2B |
| Q1 26 | $6.3B | $12.5B | ||
| Q4 25 | $6.3B | $12.7B | ||
| Q3 25 | $7.5B | $12.3B | ||
| Q2 25 | $7.3B | $12.1B | ||
| Q1 25 | $6.8B | $12.1B | ||
| Q4 24 | $6.5B | $12.1B | ||
| Q3 24 | $6.4B | $11.1B | ||
| Q2 24 | $6.8B | $11.3B |
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-390.0M |
| Free Cash FlowOCF − Capex | — | $-461.0M |
| FCF MarginFCF / Revenue | — | -27.7% |
| Capex IntensityCapex / Revenue | — | 4.4% |
| Cash ConversionOCF / Net Profit | — | -2.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $795.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-390.0M | ||
| Q4 25 | $294.0M | $650.0M | ||
| Q3 25 | $659.9M | $118.0M | ||
| Q2 25 | $303.0M | $823.0M | ||
| Q1 25 | $183.8M | $-395.0M | ||
| Q4 24 | $301.4M | $391.0M | ||
| Q3 24 | $199.5M | $213.0M | ||
| Q2 24 | $279.4M | $-9.0M |
| Q1 26 | — | $-461.0M | ||
| Q4 25 | $192.1M | $516.0M | ||
| Q3 25 | $579.4M | $13.0M | ||
| Q2 25 | $208.9M | $727.0M | ||
| Q1 25 | $96.8M | $-462.0M | ||
| Q4 24 | $176.8M | $277.0M | ||
| Q3 24 | $88.3M | $125.0M | ||
| Q2 24 | $213.3M | $-99.0M |
| Q1 26 | — | -27.7% | ||
| Q4 25 | 15.3% | 14.8% | ||
| Q3 25 | 47.9% | 0.4% | ||
| Q2 25 | 18.1% | 23.6% | ||
| Q1 25 | 9.3% | -16.9% | ||
| Q4 24 | 15.9% | 9.2% | ||
| Q3 24 | 8.9% | 4.5% | ||
| Q2 24 | 21.2% | -3.3% |
| Q1 26 | — | 4.4% | ||
| Q4 25 | 8.1% | 3.9% | ||
| Q3 25 | 6.7% | 3.3% | ||
| Q2 25 | 8.1% | 3.1% | ||
| Q1 25 | 8.4% | 2.5% | ||
| Q4 24 | 11.2% | 3.8% | ||
| Q3 24 | 11.2% | 3.2% | ||
| Q2 24 | 6.6% | 3.0% |
| Q1 26 | — | -2.62× | ||
| Q4 25 | 1.10× | 4.09× | ||
| Q3 25 | 2.33× | 0.81× | ||
| Q2 25 | 1.69× | 5.41× | ||
| Q1 25 | 1.74× | -2.65× | ||
| Q4 24 | 1.99× | 3.18× | ||
| Q3 24 | 1.48× | 2.11× | ||
| Q2 24 | 1.95× | -0.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
